The Scientific Research Team at Hexagon Bio leverages cutting-edge computational biology and synthetic biology techniques to discover novel drug candidates encoded in the global metagenome. Comprised of a multidisciplinary group of scientists, computational biologists, and research associates, the team conducts extensive research and development to identify promising compounds and advance them through preclinical stages, ultimately aiming to deliver new, effective medicines to patients.
Abigail Fine
Associate Scientist
Andrew Osborn
Senior Scientist
Bo Yuan
Scientist II
Bruno Perlatti
Principal Scientist
Cindy Bailey
Senior Research Associate
Daniel Mummau
Senior Research Associate
Eli Moss
Computational Biologist
Henry Le
Senior Scientist
Jason Pallas
Senior Research Associate
Michelle Grau
Scientist II
View all